Lamotrigine for Depression: Not Always Combined with Antidepressants
Lamotrigine (Lamictal) can be used as monotherapy for depression in bipolar disorder and does not always require co-prescription with an antidepressant, though when used for treatment-resistant unipolar depression, it is typically given as augmentation to ongoing antidepressant therapy.
Context: Bipolar Depression vs. Unipolar Depression
The answer depends critically on whether we're discussing bipolar depression or unipolar (major) depression, as the evidence and recommendations differ substantially:
For Bipolar Depression
Lamotrigine is FDA-approved for maintenance treatment of bipolar disorder and can be used as monotherapy 1. The guidelines specifically state that lamotrigine is approved for maintenance therapy in adults with bipolar disorder 1.
When antidepressants are used in bipolar depression, WHO guidelines explicitly recommend they should "always be in combination with a mood stabilizer (lithium or valproate)" 2. However, this recommendation is about adding antidepressants to mood stabilizers—not the reverse. Lamotrigine itself functions as a mood stabilizer with particular efficacy for preventing depressive episodes 3.
Key point: In bipolar disorder, lamotrigine monotherapy is appropriate for maintenance treatment and prevention of depressive episodes. It does not require concurrent antidepressant use.
For Treatment-Resistant Unipolar Depression
The evidence shows a different pattern for unipolar depression:
When lamotrigine is used for treatment-resistant unipolar depression, it is predominantly studied and used as augmentation therapy added to existing antidepressants 4, 5, 6, 7, 8. The meta-analysis by Bai et al. (2019) specifically examined "lamotrigine augmentation" in treatment-resistant unipolar depression, with all included studies using lamotrigine as an add-on to ongoing antidepressant therapy 4.
Studies consistently describe lamotrigine being "added to an antidepressant regimen" 7 or used as "adjunctive treatment" to other antidepressants 8. One comparative study directly evaluated "lamotrigine versus lithium augmentation of antidepressant therapy" 6, confirming the augmentation paradigm.
Clinical Algorithm
For Bipolar Depression:
- Lamotrigine monotherapy is appropriate for maintenance treatment
- Standard dose: 200 mg/day (achieved through slow titration)
- No antidepressant required unless treating acute severe depressive episodes
- If antidepressants are added for acute bipolar depression, they should be combined with a mood stabilizer (which lamotrigine already provides)
For Treatment-Resistant Unipolar Depression:
- Lamotrigine is used as augmentation to ongoing antidepressant therapy
- Patients should have failed at least 2 adequate antidepressant trials 7, 8
- Lamotrigine is added while continuing the existing antidepressant
- Doses studied: 50-200 mg/day 6, with mean doses of 43-113 mg/day showing efficacy 7
- Response typically seen within 2-8 weeks 6, 7
Important Caveats
Monotherapy in unipolar depression: While one case report described successful lamotrigine monotherapy for persistent depressive disorder after antidepressants were tapered 9, this represents an exception rather than standard practice. The bulk of evidence supports augmentation rather than replacement.
Drug interactions matter: Dosing must be adjusted based on concomitant medications 10:
- Valproate increases lamotrigine levels 2-fold (reduce lamotrigine to 100 mg/day)
- Enzyme inducers (carbamazepine, phenytoin) decrease lamotrigine by ~40% (may need up to 400 mg/day)
- Oral contraceptives decrease lamotrigine by ~50%
Safety considerations: Slow titration is essential to minimize risk of serious rash (0.1% in adults) 3. Lamotrigine is generally well-tolerated with low discontinuation rates 4, 5.
Bottom Line
Your statement is partially correct but oversimplified. Lamotrigine's use with antidepressants depends on the diagnosis:
- Bipolar disorder: Lamotrigine monotherapy is appropriate and FDA-approved
- Treatment-resistant unipolar depression: Lamotrigine is typically used as augmentation to ongoing antidepressants, not as monotherapy
The evidence strongly supports augmentation (not monotherapy) for unipolar depression, while bipolar depression can be treated with lamotrigine alone, particularly for maintenance and prevention of depressive episodes.